Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Peptides for Athletic Performance: Category Comparison

Growth Hormone Secretagogues (GHRP-2, Ipamorelin, MK-677) Bind to ghrelin receptors in pituitary gland, triggering endogenous GH release and downstream IGF-1 synthesis 100–300mcg 1–3× daily, pre-sleep or pre-workout GH spike within 30 minutes; tissue effects a

This comparison does not assign a generated winner or score.

  • Growth Hormone Secretagogues (GHRP-2, Ipamorelin, MK-677)
  • Bind to ghrelin receptors in pituitary gland, triggering endogenous GH release and downstream IGF-1 synthesis
  • 100–300mcg 1–3× daily, pre-sleep or pre-workout
  • GH spike within 30 minutes; tissue effects accumulate over 4–8 weeks
  • Most clinically validated category with robust human trial data. Effective for lean mass gain and recovery when dosed correctly
  • Tissue Repair Peptides (TB-500, BPC-157)
  • Promote cell migration, angiogenesis, and collagen synthesis directly at injury sites via VEGF and growth factor modulation
  • TB-500: 2–2.5mg 2× weekly; BPC-157: 250–500mcg daily for 4–6 weeks
  • Gradual improvement over 2–4 weeks as tissue remodeling occurs
  • Strongest evidence for localized tendon and ligament injuries. Not a quick fix but accelerates healing beyond passive recovery
  • Mitochondrial Peptides (MOTS-c, Humanin)
  • Activate AMPK and protect mitochondrial function, improving fat oxidation and reducing oxidative stress
  • MOTS-c: 5–10mg 2–3× weekly; Humanin: protocols still emerging
  • Metabolic shifts within days; endurance gains accumulate over weeks
  • Cutting-edge research area with promising mechanisms but limited long-term human data. Best suited for endurance athletes
  • Immune Modulation Peptides (Thymalin)
  • Support thymus function and T-cell production, critical for maintaining immune competence during heavy training
  • Variable based on research design
  • Immune markers improve over 2–3 weeks
  • Useful for athletes experiencing recurrent illness during high-volume phases. Thymalin represents research-grade options
More references

Related material